| First Author | Kanuri B | Year | 2021 |
| Journal | J Lipid Res | Volume | 62 |
| Pages | 100028 | PubMed ID | 33524375 |
| Mgi Jnum | J:304449 | Mgi Id | MGI:6690337 |
| Doi | 10.1016/j.jlr.2021.100028 | Citation | Kanuri B, et al. (2021) Generation and validation of a conditional knockout mouse model for desmosterolosis. J Lipid Res 62:100028 |
| abstractText | The enzyme 3beta-hydroxysterol-Delta24 reductase (DHCR24, EC 1.3.1.72) catalyzes the conversion of desmosterol to cholesterol and is obligatory for post-squalene cholesterol synthesis. Genetic loss of this enzyme results in desmosterolosis (MIM #602398), a rare disease that presents with multiple congenital anomalies, features of which overlap with subjects with the Smith-Lemli-Opitz syndrome (another post-squalene cholesterol disorder). Global knockout (KO) of Dhcr24 in mice recapitulates the biochemical phenotype, but pups die within 24 h from a lethal dermopathy, limiting its utility as a disease model. Here, we report a conditional KO mouse model (Dhcr24(flx/flx)) and validate it by generating a liver-specific KO (Dhcr24(flx/flx,Alb-Cre)). Dhcr24(flx/flx,Alb-Cre) mice showed normal growth and fertility, while accumulating significantly elevated levels of desmosterol in plasma and liver. Of interest, despite the loss of cholesterol synthesis in the liver, hepatic architecture, gene expression of sterol synthesis genes, and lipoprotein secretion appeared unchanged. The increased desmosterol content in bile and stool indicated a possible compensatory role of hepatobiliary secretion in maintaining sterol homeostasis. This mouse model should now allow for the study of the effects of postnatal loss of DHCR24, as well as role of tissue-specific loss of this enzyme during development and adulthood. |
